Standard Biotools (LAB): Director bought ~$47K

~$47K

Approx. value · 75K sh @ $0.6253

419K

Holds after · shares reported

Traded

Nov 5, 2026

Filed

Nov 5, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 30, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 1 more item)
2. Nov 5, 2026 · this disclosureInsider · First insider buy since Sep 2025Director purchased ~$47K of LAB shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Standard Biotools

For Standard Biotools, OQRO holds 1 insider filing (SEC Form 4 or Form 144) and 1 federal contract award dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LAB page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Standard Biotools

• USAspending.gov award recordSep 2, 2026
• SEC Form 13F-HRMay 12, 2026
• USAspending.gov award recordFeb 26, 2026
• SEC Form 13F-HRFeb 11, 2026
• SEC Form 13F-HRNov 12, 2025
• SEC Form 4Sep 12, 2025

Everything OQRO holds on this company is on its LAB page.